We demonstrated an enhanced anticancer effects of Smad3−/− NK cells in cancer progression whereby mice infused with Smad3−/− NK1.1+ cells displayed reduced tumour growth compared with Smad3+/+ NK1.1+ cell-recipient mice. Here, SMAD3 is linked to neoplasm.